Cancer News and Research

Latest Cancer News and Research

Researchers to estimate air pollution using GPS-equipped smart phone

University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.

9 Feb 2011

Study finds dutasteride not cost-effective in prevention of prostate cancer in men at elevated risk

The popular drug dutasteride may not be a cost-effective way to prevent prostate cancer in men who are at elevated risk of developing the disease, according to findings by a UT Southwestern Medical Center researcher.

9 Feb 2011

Rational use of heath care dollars for tonsillectomy

Without fanfare, hundreds of thousands of children surrender their tonsils to a surgeon's scalpel each year, usually to alleviate recurring infections and obstructive sleep problems. Most of the time, the snipped tonsils are sent to a pathologist, who looks for evidence of more serious medical problems, like unsuspected cancer.

9 Feb 2011

Tulane surgeon performs new robotic-assisted surgery to treat head, neck cancers

Tulane University School of Medicine surgeon Dr. Paul Friedlander is performing a new, less-invasive form of robotic surgery to treat head and neck cancers.

9 Feb 2011

bcl3 gene limits lung injury during acute stress from illness, trauma, transplant

Lung injury is a common cause of death among patients with pneumonia, sepsis or trauma and in those who have had lung transplants. The damage often occurs suddenly and can cause life-threatening breathing problems and rapid lung failure.

9 Feb 2011

Vical announces issuance of US patent for HSV-2 vaccine

Vical Incorporated announced today the issuance of U.S. Patent No. 7,879,339, assigned to Vical and the University of Washington, covering DNA vaccines for herpes simplex virus type 2.

9 Feb 2011

LESSOnc technique promising new surgical option for certain liver cancers

Surgeons at UC San Diego Health System have identified a new application for "scarless" surgery tools that are normally used for natural orifice translumenal endoscopic surgery (NOTES).

9 Feb 2011

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

9 Feb 2011

Study finds link between sleep duration and colorectal adenomas

An inadequate amount of sleep has been associated with higher risks of obesity, heart disease, diabetes, and death. Now colon cancer can be added to the list.

9 Feb 2011

Pervasis' Vascugel granted Fast Track review status for prevention of hemodialysis access failure in ESRD patients

Pervasis Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track review status for Vascugel® for the prevention of hemodialysis access failure in patients with end stage renal disease (ESRD).

9 Feb 2011

Physician offers tips to kick-off heart disease and its risk factors

The health statistics are heart-stopping for Hispanic communities: the leading cause of death among both Hispanic men and women is cardiovascular disease.

9 Feb 2011

NMS Labs launches unique test for Methotrexate

NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy and helping physicians with therapeutic drug monitoring of patients for the therapeutic agent, Methotrexate.

8 Feb 2011

CytRx's bafetinib helps reduce skeletal complications in cancer patients

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.

8 Feb 2011

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".

8 Feb 2011

ASBP concerned over FDA rejection of Contrave drug

The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.

8 Feb 2011

Study estimates 1.3 million cancer deaths in Europe in 2011

There will be nearly 1.3 million deaths from cancer in Europe in 2011 according to predictions from a study published in the cancer journal, Annals of Oncology today.

8 Feb 2011

FDA approves Medtronic's new Revo MRI pacemaker

Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.

8 Feb 2011

Reducing the cardiovascular disease gender gap

The European Society of Cardiology (ESC) is working with the National Cardiac Societies of its 53 member countries on a project to raise awareness of the disturbing gender gap in cardiovascular disease (CVD). In partnership with the European Heart Network (EHN) and the World Heart Federation (WHF), the ESC has developed the Women@Heart contest in which national societies submit ideas for public awareness campaigns aimed at informing both health professionals and women of the dangers of complacency about CVD.

8 Feb 2011

Cancer cells emerge as ghosts from the past: Literally

Cancer is growing by the day worldwide and the cancer cells still manage to evade both the body’s defenses and medical intervention. Now an explanation to the phenomenon is provided by an Arizona State University scientist.

8 Feb 2011

Anti-cancer shots for boys in the pipeline

The Pharmaceutical Benefits Advisory Committee (PBAC) is deciding on whether to include the human papillomavirus (HPV) vaccine, Gardasil in in the National Immunization Program for boys.

8 Feb 2011